Alan Goldhammer, vice president for scientific and regulatory affairs at the Pharmaceutical Research and Manufacturers of America, said the industry will study the suggestions and weigh whether to incorporate them.
Perhaps the Kaplan-Goldhammer team will turn their attention to the essays of "L'Envers et l'endroit" and "Noces, " books about a country that no longer exists by one of the 20th century's most enduring writers.